The Pharma Solutions division of Piramal Pharma Limited, a leading contract development and manufacturing company (CDMO), announced today that at the company’s pharmaceuticals site in Pithampur, Madhya Pradesh, India, a new production block was commissioned.
The new production area, known as the V-Block, can process batch sizes from 150 to 600 kilograms and expands the site’s capacity for manufacturing pharmaceuticals in solid oral dosage form. With the addition of the V-Block, the overall production capacity of the Pithampur site will increase from 3 billion cans to 4.5 billion cans. The V-Block includes technology for aqueous and non-aqueous wet granulation (high shear, top spray and bottom spray), direct, mono and two-layer compression, aqueous and non-aqueous coating, and bottle packaging. Aggregation capacities in line with US FDA requirements for e-Pedigree and Track & Trace are planned for the V-Block, as well as the addition of dry granulation capacities (roller compaction).
Peter DeYoung , Chief Executive Officer, Piramal Pharma Solutions, said: “By starting up this new major manufacturing block, we are greatly expanding our ability to supply oral solid dose medicines to customers around the world. With this additional capacity, we reaffirm our commitment to be a patient-centric company and to help our customers alleviate patient suffering.”
The Pithampur site employs around 600 people and supplies biotech customers, small and large pharmaceutical companies and large generic companies around the world with pharmaceuticals that are required for both patent and generic medicines. The site has been successfully inspected by a number of regulatory bodies including the FDA ( US ), MHRA (UK), MPA (Sweden), TGA (Australia), FIMEA (Finland) and ANVISA (Brazil), the statement said.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.